Effect of nucleic acid amplification testing on population-based incidence rates of Clostridium difficile infection.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 23899677.
- Also identified by DOI 10.1093/cid/cit492 and PMC identifier 9580544.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Nucleic acid amplification testing (NAAT) is increasingly being adopted for diagnosis of Clostridium difficile infection (CDI). Data from 3 states conducting population-based CDI surveillance showed increases ranging from 43% to 67% in CDI incidence attributable to changing from toxin enzyme immunoassays to NAAT. CDI surveillance requires adjustment for testing methods.
Medical subject headings
- Clostridium Infections
- Molecular Diagnostic Techniques
- Nucleic Acid Amplification Techniques